ESAT6-CFP10

recombinant Mycobacterium tuberculosis allergen ESAT6-CFP10 · Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for ESAT6-CFP10, covering 2017-03-17 to 2017-03-23. Get the full timeline:

Most recent: Clinical Trial Update: Phase IIb Clinical Study of Recombinant Mycobacterium Tuberculosis Allergen ESAT6-CFP10 [Phase 2]